D-0169-2017 Class III Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-0169-2017 was initiated by Hospira Inc. on Jun 29, 2016 and is designated Class III. Reason for recall: Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life. The recall status is terminated (terminated Nov 20, 2019). Affected quantity: 287,200 2 mL ampules.

Recall details

Product Type
Drugs
Report Date
Dec 14, 2016
Initiation Date
Jun 29, 2016
Termination Date
Nov 20, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
287,200 2 mL ampules

Product description

5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Reason for recall

Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

Distribution pattern

US and Puerto Rico

Code information

Lot # 34-547-DK, 34-548-DK, Exp. 10/16, Lot # 39-372-DK, Exp. 03/17 Lot Number may be followed by numbers from 01 to 99

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0169-2017
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0169-2017. Report a data issue: hello@regdatalab.com.